FLUDEOXYGLUCOSE [F-18] FDG INJECTION SOLUTION

Quốc gia: Canada

Ngôn ngữ: Tiếng Anh

Nguồn: Health Canada

Thành phần hoạt chất:

FLUDEOXYGLUCOSE 18F

Sẵn có từ:

THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE

Mã ATC:

V09IX04

INN (Tên quốc tế):

FLUDEOXYGLUCOSE (18F)

Liều dùng:

0.5GBQ

Dạng dược phẩm:

SOLUTION

Thành phần:

FLUDEOXYGLUCOSE 18F 0.5GBQ

Tuyến hành chính:

INTRAVENOUS

Các đơn vị trong gói:

100

Loại thuốc theo toa:

Schedule C

Khu trị liệu:

ROENTGENOGRAPHY

Tóm tắt sản phẩm:

Active ingredient group (AIG) number: 0152591001; AHFS:

Tình trạng ủy quyền:

APPROVED

Ngày ủy quyền:

2018-06-13

Đặc tính sản phẩm

Fludeoxyglucose (
18
F)
1
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
FDG(
18
F)
Fludeoxyglucose (
18
F)
Intravenous solution, >0.5 GBq/vial or syringe
Diagnostic Radiopharmaceutical
Thunder Bay Regional Health Sciences Centre
980 Oliver Rd
Thunder Bay ON P7B 6V4
Date of Preparation:
June 22
nd
, 2017
Submission Control #: 201447
Date of Approval: November 08, 2017
Fludeoxyglucose (
18
F)
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..................................................... 4
1
INDICATIONS
.........................................................................................................
4
1.1
Pediatrics
........................................................................................................
4
1.2
Geriatrics
........................................................................................................
4
2
CONTRAINDICATIONS
.........................................................................................
4
3
SERIOUS WARNINGS AND PRECAUTIONS
....................................................... 4
4
DOSAGE AND ADMINISTRATION
........................................................................
5
4.1
Dosing considerations
....................................................................................
5
4.2
Dosage
...........................................................................................................
5
4.3
Administration
.................................................................................................
5
4.4
Image Acquisition and Interpretation
.............................................................. 5
4.5
Instructions for Preparation and Use
.............................................................. 6
4.6
Directions for Quality Control
..........................................................................
6
5
RADIATION DOSIMETRY
......................................................................................
7
6
OVERDOSAGE
..................................................